Endoscopic band ligation a better technique to treat Gastric antral vascular Ectasia: Study

The results of the study was found to be as follows

• A total of 10-studies (194 patients) were included in the final analysis. The pooled rate of treatment responders with EBL in GAVE was 81% (95% CI, 62.2-91.7) and GAVE recurrence was 15.4% (95% CI, 4.5-41.3).

• The pooled mean number of treatment sessions required was 2.4 (95% CI, 2.2-2.7), and the number of bands used to achieve eradication per patient was 15.1 (95% CI,10.7-19.4).

• The pooled mean difference of pre- to post-treatment Hb was 1.5 (95% CI, 0.9-2.2; p=0.001).

• Pre- to post-treatment units of PRBCs transfused was 1.1 (95% CI, 0.4-1.9; p=0.002); and pre- to post-treatment hospital length of stay was 0.5 (95% CI, 0.1-0.9; p=0.01).

• The pooled rate of overall adverse events was 15.9% (95% CI, 10.4-23.7).

Dr Mohan and team concluded that "Endoscopic band ligation (EBL) demonstrated excellent clinical outcomes in the treatment of GAVE with minimal adverse events. Multicenter RCTs comparing EBL and other modalities as initial therapy are warranted."

For further information: https://doi.org/10.1016/j.gie.2021.08.017